Stephen K. Brannan - Net Worth and Insider Trading

Stephen K. Brannan Net Worth

The estimated net worth of Stephen K. Brannan is at least $14 Million dollars as of 2024-05-12. Stephen K. Brannan is the Chief Medical Officer of Karuna Therapeutics Inc and owns about 42,604 shares of Karuna Therapeutics Inc (KRTX) stock worth over $14 Million. Details can be seen in Stephen K. Brannan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen K. Brannan has not made any transactions after 2024-03-08 and currently still holds the listed stock(s).

Transaction Summary of Stephen K. Brannan

To

Stephen K. Brannan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen K. Brannan owns 1 companies in total, including Karuna Therapeutics Inc (KRTX) .

Click here to see the complete history of Stephen K. Brannan’s form 4 insider trades.

Insider Ownership Summary of Stephen K. Brannan

Ticker Comapny Transaction Date Type of Owner
KRTX Karuna Therapeutics Inc 2024-03-08 Chief Medical Officer

Stephen K. Brannan Latest Holdings Summary

Stephen K. Brannan currently owns a total of 1 stock. Stephen K. Brannan owns 42,604 shares of Karuna Therapeutics Inc (KRTX) as of March 8, 2024, with a value of $14 Million.

Latest Holdings of Stephen K. Brannan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KRTX Karuna Therapeutics Inc 2024-03-08 42,604 329.83 14,052,077

Holding Weightings of Stephen K. Brannan


Stephen K. Brannan Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen K. Brannan has made a total of 31 transactions in Karuna Therapeutics Inc (KRTX) over the past 5 years, including 0 buys and 31 sells. The most-recent trade in Karuna Therapeutics Inc is the sale of 5,000 shares on March 8, 2024, which brought Stephen K. Brannan around $2 Million.

Insider Trading History of Stephen K. Brannan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen K. Brannan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephen K. Brannan Ownership Network

Ownership Network List of Stephen K. Brannan

No Data

Ownership Network Relation of Stephen K. Brannan


Stephen K. Brannan Owned Company Details

What does Karuna Therapeutics Inc do?

Who are the key executives at Karuna Therapeutics Inc?

Stephen K. Brannan is the Chief Medical Officer of Karuna Therapeutics Inc. Other key executives at Karuna Therapeutics Inc include Chief Financial Officer Jason Parker Brown , Chief Financial Officer Troy A. Ignelzi , and Chief Operating Officer Andrew Craig Miller .

Karuna Therapeutics Inc (KRTX) Insider Trades Summary

Over the past 18 months, Stephen K. Brannan made 13 insider transaction in Karuna Therapeutics Inc (KRTX) with a net sale of 80,000. Other recent insider transactions involving Karuna Therapeutics Inc (KRTX) include a net sale of 34,017 shares made by Troy A. Ignelzi , a net sale of 41,429 shares made by Jeffrey M Jonas , and a net sale of 60,000 shares made by Andrew Craig Miller .

In summary, during the past 3 months, insiders sold 5,000 shares of Karuna Therapeutics Inc (KRTX) in total and bought 0 shares, with a net sale of 5,000 shares. During the past 18 months, 222,473 shares of Karuna Therapeutics Inc (KRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 222,473 shares.

Karuna Therapeutics Inc (KRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Karuna Therapeutics Inc Insider Transactions

No Available Data

Stephen K. Brannan Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen K. Brannan. You might contact Stephen K. Brannan via mailing address: C/o Karuna Therapeutics, Inc., 33 Arch Street, Suite 3110, Boston Ma 02110.

Discussions on Stephen K. Brannan

No discussions yet.